Biomarker concordance between primary colorectal cancer and its metastases

BACKGROUND: The use of biomarkers to target anti-EGFR treatments for metastatic colorectal cancer (CRC) is well-established, requiring molecular analysis of primary or metastatic biopsies. We aim to review concordance between primary CRC and its metastatic sites. METHODS: A systematic review and met...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhullar, D.S., Barriuso, J., Mullamitha, S., Saunders, M.P., O'Dwyer, S.T., Aziz, O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Research paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6413540/
https://www.ncbi.nlm.nih.gov/pubmed/30733075
http://dx.doi.org/10.1016/j.ebiom.2019.01.050

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6413540/
https://www.ncbi.nlm.nih.gov/pubmed/30733075
http://dx.doi.org/10.1016/j.ebiom.2019.01.050

Ejemplares similares